Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)

Market Cap	2.30B +0.5%
Revenue (ttm)	5.38B +5.3%
Net Income	-4.78M
EPS	-0.02
Shares Out	205.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.04 (0.40%)
Ex-Dividend Date	Dec 15, 2025

Volume	3,927,610
Average Volume	4,169,432
Open	11.08
Previous Close	11.07
Day's Range	11.03 - 11.32
52-Week Range	8.71 - 14.90
Beta	0.73
RSI	39.16
Earnings Date	Apr 28, 2026

About SHE:301126

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages, drinks, and probiotic beverages; and cleansing and care products. In addition, it provides pharmaceutical logistics services; and operates reproducti...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2002
• Employees: 4,887
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301126

Financial Performance

In 2024, SHE:301126's revenue was 5.23 billion, an increase of 34.07% compared to the previous year's 3.90 billion. Earnings were 26.57 million, a decrease of -22.52%.